• EPO Revokes Regenlab PRP Patent americanpharmaceuticalreview
    May 22, 2019
    Estar Technologies announced the Opposition Division of the European Patent Office (EPO) has revoked Regen Lab SA (Regenlab)'s platelet rich plasma (PRP) patent in its entirety due to lack of novelty and added matter.
PharmaSources Customer Service